找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiotherapy in Managing Brain Metastases; A Case-Based Approac Yoshiya Yamada,Eric Chang,Jonathan Knisely Book 2020 Springer Nature Switze

[復(fù)制鏈接]
樓主: coherent
21#
發(fā)表于 2025-3-25 03:28:49 | 只看該作者
Introduction,The development of stereotactic radiosurgery for the treatment of brain metastases has been an evolution of improvements in technology coupled with paradigm shifts in oncology, providing a highly effective therapy for an otherwise clinically vexing problem. The historical development of this seminal medical innovation is described.
22#
發(fā)表于 2025-3-25 08:36:11 | 只看該作者
23#
發(fā)表于 2025-3-25 12:15:08 | 只看該作者
24#
發(fā)表于 2025-3-25 18:25:50 | 只看該作者
25#
發(fā)表于 2025-3-25 21:52:00 | 只看該作者
26#
發(fā)表于 2025-3-26 00:18:53 | 只看該作者
978-3-030-43742-8Springer Nature Switzerland AG 2020
27#
發(fā)表于 2025-3-26 06:14:28 | 只看該作者
Supportive Medical Management of Brain Metastases Patients Including Treatment Complicationsent. These include focal neurologic deficits, seizures, cognitive impairment, and headache. We will review the data regarding the management of these problems. Iatrogenic sequelae and radiotherapy-related complications such as radiation necrosis will also be specifically addressed.
28#
發(fā)表于 2025-3-26 10:12:19 | 只看該作者
Radiobiology of Stereotactic Radiosurgerynized that the immune system, which plays key roles in tumor surveillance and suppression, is an integral component of the SRS response. In addition to the hypothesis that SBRT may be able to overcome tumor-induced immunosuppression, there is tremendous excitement that SBRT could act synergistically
29#
發(fā)表于 2025-3-26 15:17:38 | 只看該作者
Indications for Whole-Brain Radiation Therapyive to WBRT in patients with 4–15 metastases, though the results of randomized trials are awaited. Newer systemic therapies such as targeted therapy and immunotherapy have demonstrated relatively high rates of intracranial response for patients with limited intracranial disease, though the optimal s
30#
發(fā)表于 2025-3-26 18:22:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-11-1 05:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
迁安市| 高青县| 喀喇沁旗| 仙游县| 淮阳县| 岗巴县| 横山县| 咸丰县| 黑山县| 南开区| 瓮安县| 太仓市| 静宁县| 临邑县| 乌兰县| 原阳县| 得荣县| 长治县| 云安县| 海兴县| 中山市| 奈曼旗| 遂溪县| 镇坪县| 廊坊市| 三明市| 大冶市| 共和县| 淮安市| 寿光市| 绥德县| 富平县| 景东| 鞍山市| 铅山县| 梁平县| 吴忠市| 屯门区| 新乐市| 孟连| 高雄县|